ArticleGene therapy2023

Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA.

Andrés Felipe Leal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.